Healthcare Tracked since Q4 FY26 - Q4 FY26

RPG Life Sciences Limited

Compare with...

RPGLIFESCIENCES

Latest quarter Q4 FY26

Revenue ₹177 Cr (+23.6% YoY)

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for RPG Life Sciences Limited

Latest signal bullish high

RPG Life Sciences delivered a strong Q4 FY26 with revenue of 176.9 cr (+23.6% YoY) and EBITDA of 45.2 cr (+48% YoY),...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 13 May 2026

Revenue ₹177 Cr (+23.6% YoY)

RPG Life Sciences delivered a strong Q4 FY26 with revenue of 176.9 cr (+23.6% YoY) and EBITDA of 45.2 cr (+48% YoY), driven by domestic formulation growth of 18.2% (1....

bullish high

Scorecard starts after historical backfill Read full analysis →